Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Pharma pushes for higher European drug prices, Trump or no Trump
Just over a year ago, US President Trump issued an executive orderExternal link calling for US drug prices to align with so-called Most-Favoured Nation (MFN) prices – those paid in other developed countries. On average, Americans pay three…
CSL names British pharma executive as new CEO
Healthcare giant CSL has named British pharmaceutical executive Deborah Waterhouse as its new chief executive following a six-month global search. Waterhouse, a senior executive at British company GSK, will replace interim chief executive Gordon…
Sun Pharma Board Authorizes Up to ₹10,000 Crore in Bonds
Sun Pharmaceutical Industries Limited (Sun Pharma) has authorized up to ₹10,000 crore in bonds, which Reuters and The Economic Times reported would refinance borrowing for its proposed Organon & Co. acquisition. The Oct. 12 board decision…
Orchid Pharma Board Approves Exploring a Raise of Up to Rs 600 Crore
Orchid Pharma Limited's board approved exploring a capital raise of up to Rs 600 crore, while Infosys expanded its Truist partnership, putting financing and technology work in focus for Indian investors Wednesday, Oct. 21. Orchid's authorization…
Skin Cancer Guidelines Add UNLOXCYT as Category 2A Option, Sun Pharma Says
Sun Pharmaceutical Industries Limited (Sun Pharma) said the National Comprehensive Cancer Network (NCCN) gave UNLOXCYT a Category 2A recommendation for locally advanced skin cancer, a designation that may inform U.S. coverage decisions. According…
Apothecary Pharma Recalls Tirzepatide Vials Nationwide
A Cary, North Carolina pharmacy is recalling 22 vials of compounded tirzepatide after federal regulators said the company cannot assure the products were made sterile, and the recall has already shipped nationwide. Apothecary Pharma LLC initiated…
BridgeBio Pharma (BBIO) Expected to Release Quarterly Earnings on Wednesday
BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) is expected to be releasing its Q3 2026 results after the market closes on Wednesday, October 28th. Analysts expect the company to post earnings of ($0.5437) per share and revenue of $288.74 million…
Spyglass Pharma, Inc. (NASDAQ:SGP) Stock Has Average Price Target of $44.00
Shares of Spyglass Pharma, Inc. (NASDAQ:SGP - Get Free Report) have been given an average recommendation of 'Moderate Buy' by the nine brokerages that are currently covering the firm, Marketbeat Ratings reports. One equities research analyst has…
OpenAI acquires startup Orchestra Bio to beef up its biotech business
OpenAI on Tuesday acquired a four-year-old AI biotech software startup called Orchestra Bio, the company announced via its website. Terms of the deal were not disclosed, but the startup had reportedly raised around $20 million as of 2025 from…
Ascendis Pharma A/S $ASND Shares Purchased by Assenagon Asset Management S.A.
Assenagon Asset Management S.A. lifted its stake in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 1,105.9% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm…
Ascendis Pharma A/S (NASDAQ:ASND) Stock Has Consensus Price Target of $309.26 According to Analysts
Shares of Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) have been assigned a consensus recommendation of 'Buy' from the twenty analysts that are covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a…
Stocks to watch out for today, October 21: Infosys, Ceigall, Dhampur Bio, JSW Dulux, Venus Pipes, Transrail, Orchid Pharma among 15 stocks in focus
Infosys has announced the expansion of its collaboration with Truist, one of the largest US-based financial services companies, to support the bank's continued build-out of its AI-first Global Capability Center in Hyderabad. Together with Infosys…
Avalyn Pharma (NASDAQ:AVLN) Reaches New 52-Week Low - Should You Sell?
Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report)'s stock price hit a new 52-week low during trading on Tuesday. The stock traded as low as $22.24 and last traded at $23.57, with a volume of 9,188 shares. The stock had previously closed at $23.33.
STAG Industrial: Buy Reaffirmed Ahead Of Q3 Earnings, Amid Tailwind From E-Commerce
Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…
HSE could be saving nearly €150m annually by using more biosimilar drugs
The Health Service Executive could save €149 million annually by making greater use of lower-cost biosimilars – cheaper copies of expensive biological drugs – the Irish and UK head of Swiss pharma group Sandoz has claimed.
Receive a Daily briefing on Pharma Industry News
Get Started